When can we stop nucleoside analogues in patients with chronic hepatitis B?

  • Chern Hao Chong, Seng Gee Lim
  • Liver International, January 2017, Wiley
  • DOI: 10.1111/liv.13314

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/liv.13314

The following have contributed to this page: Seng Gee Lim

In partnership with:

Contributors